Quantification of serum 1-84 parathyroid hormone in patients with hyperparathyroidism by immunocapture in situ digestion liquid chromatography-tandem mass spectrometry.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Clinical Chemistry

• Publication date

  2010-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1373/clinchem.2009.134643PMID 20007860
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Multiple Reaction Monitoring-based, Multiplexed, Absolute Quantitation of 45 Proteins in Human Plasma*

  2009cited by this paper
• Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma

  2009cited by this paper
• Quantification of thyroglobulin, a low-abundance serum protein, by immunoaffinity peptide enrichment and tandem mass spectrometry.

  2008cited by this paper
• Advances in male contraception.

  2008cited by this paper
• "Product ion monitoring" assay for prostate-specific antigen in serum using a linear ion-trap.

  2008cited by this paper
• Antihypertensive therapy in the presence of proteinuria.

  2007cited by this paper
• LC-MS/MS Quantification of Zn-α2 Glycoprotein: A Potential Serum Biomarker for Prostate Cancer

  2007cited by this paper
• Large scale preparation of recombinant human parathyroid hormone 1-84 from Escherichia coli.

  2007cited by this paper
• LC-MS/MS quantification of Zn-alpha2 glycoprotein: a potential serum biomarker for prostate cancer.

  2007cited by this paper
• KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease.

  2007cited by this paper
• Lack of comparability of intact parathyroid hormone measurements among commercial assays for end-stage renal disease patients: implication for treatment decisions.

  2006cited by this paper
• Identification of carboxyl-terminal peptide fragments of parathyroid hormone in human plasma at low-picomolar levels by mass spectrometry.

  2006cited by this paper
• Structure of non-(1-84) PTH fragments secreted by parathyroid glands in primary and secondary hyperparathyroidism.

  2005cited by this paper
• Editorials: Parathyroid Hormone Assay Drift: An Unappreciated Problem in Dialysis Patient Management

  2005cited by this paper
• Parathyroid hormone secretion and action: evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl- terminal ligands.

  2005cited by this paper
• Mass spectrometric quantitation of peptides and proteins using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA).

  2004cited by this paper
• Absolute quantification of the model biomarker prostate-specific antigen in serum by LC-Ms/MS using protein cleavage and isotope dilution mass spectrometry.

  2004cited by this paper
• Parathyroid hormone assays--evolution and revolutions in the care of dialysis patients.

  2003cited by this paper
• Ion suppression in mass spectrometry.

  2003cited by this paper
• Clinical utility of an immunoradiometric assay for parathyroid hormone (1-84) in primary hyperparathyroidism.

  2003cited by this paper
• Comparison of two third-generation parathyroid hormone assays.

  2003cited by this paper
• Validation of a high-throughput liquid chromatography-tandem mass spectrometry method for urinary cortisol and cortisone.

  2002cited by this paper
• Human PTH-(7-84) inhibits bone resorption in vitro via actions independent of the type 1 PTH/PTHrP receptor.

  2002cited by this paper
• Development of a Novel Immunoradiometric Assay Exclusively for Biologically Active Whole Parathyroid Hormone 1–84: Implications for Improvement of Accurate Assessment of Parathyroid Function

  2001cited by this paper
• Synthetic carboxyl-terminal fragments of parathyroid hormone (PTH) decrease ionized calcium concentration in rats by acting on a receptor different from the PTH/PTH-related peptide receptor.

  2001cited by this paper
• PTH and PTHrP: Similar Structures but Different Functions.

  1999cited by this paper
• Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: importance in the interpretation of PTH values.

  1996cited by this paper
• Isotope dilution--mass spectrometric quantification of specific proteins: model application with apolipoprotein A-I.

  1996cited by this paper

• Quantification and clinical performance of serum parathyroid hormone 1-84 via immunocapture coupled to LC-MS/MS in chronic renal failure.

  2025cites this paper
• Quantification of parathyroid hormone in high-purity materials by two isotope dilution mass spectrometry methods

  2025cites this paper
• Unlocking the mysteries of n-oxPTH: implications for CKD patients

  2025cites this paper
• Parathyroid hormone assay standardization in CKD-MBD: resolving heterogeneity for precision medicine

  2025cites this paper
• Antibody-Free Inline Dual-Retention Nano-WCX-μSPE-MS/MS for Quantification of Intact Parathyroid Hormone and Antagonistic Fragments in Clinical Serum.

  2025cites this paper
• Biochemical evaluation of X-linked hypophosphatemia and tumor-induced osteomalacia: insights into diagnosis and management

  2025cites this paper
• SAT-763 A Case of Parathyroid Crisis with EKG Changes Mimicking ST Elevation Myocardial Infarct

  2025cites this paper
• LC-MS/MS: a powerful tool for modern analytical science: Fundamentals, techniques, applications and innovations

  2025cites this paper
• Immunoproteomics: A Review of Techniques, Applications, and Advancements.

  2024cites this paper
• Asymptomatic elevation of parathyroid hormone levels by antibodies against reagent alkaline phosphatase.

  2024cites this paper
• Multiple Reaction Monitoring–Mass Spectrometric Immunoassay Analysis of Parathyroid Hormone Fragments with Vitamin D Deficiency in Patients with Diabetes Mellitus

  2024cites this paper
• Impact of Variation between Assays and Reference Intervals in the Diagnosis of Endocrine Disorders

  2023cites this paper
• Determination of parathyroid hormone: from radioimmunoassay to LCMS/MS

  2023cites this paper
• Concise review on the combined use of immunocapture, mass spectrometry and liquid chromatography for clinical applications

  2023cites this paper
• Preanalytical considerations in parathyroid hormone measurement.

  2022cites this paper
• Quantification of Parathyroid Hormone and its Fragments in Serum by Liquid Chromatography-High-Resolution Mass Spectrometry.

  2022cites this paper
• Validation of an LC-MS/MS Method Using Solid-Phase Extraction for the Quantification of 1-84 Parathyroid Hormone: Toward a Candidate Reference Measurement Procedure.

  2022cites this paper
• Qualitative and quantitative comparison of different commercially available 1-84 parathyroid hormone proteins to the WHO international standard 95/646 using orthogonal methods.

  2022cites this paper
• High-Resolution Mass Spectrometry for the Measurement of PTH and PTH Fragments: Insights into PTH Physiology and Bioactivity.

  2022cites this paper
• Aptamer-based enrichment of TDP-43 from human cells and tissues with quantification by HPLC-MS/MS.

  2021cites this paper
• Parathyroid hormone.

  2021cites this paper
• Chemical Characterization and Quantification of Circulating Intact PTH and PTH Fragments by High-Resolution Mass Spectrometry in Chronic Renal Failure

  2021cites this paper
• Novel sequential immunocapture microflow LC/MS/MS approach to measuring PTH-Fc protein in human serum.

  2021cites this paper
• Proteoforms and their expanding role in laboratory medicine

  2021cites this paper
• On-line duplex molecularly imprinted solid-phase extraction for analysis of low-abundant biomarkers in human serum by liquid chromatography-tandem mass spectrometry.

  2021cites this paper
• Should clinical laboratories adapt to the reality of chronic kidney disease in the determination of parathyroid hormone?

  2021cites this paper
• PTH Measurement in CKD

  2020cites this paper
• Proteomic Applications in Pathology and Laboratory Medicine: Present State and Future Prospects.

  2020cites this paper
• Parathyroid Glands in Chronic Kidney Disease

  2020cites this paper
• Parathyroid hormone results interpretation in the background of variable analytical performance

  2019influential citation
• Sample Preparation for LC‐MS Bioanalysis of Proteins

  2019cites this paper
• Sample Preparation for LC‐MS Bioanalysis of Peptides

  2019cites this paper
• Parathyroid Hormone Measurement in Chronic Kidney Disease: From Basics to Clinical Implications

  2019cites this paper
• A competitive lateral flow assay for the detection of tenofovir.

  2018cites this paper
• Bioanalytical Studies of the Assessment of Vitamin D Status

  2017cites this paper
• Antibody based affinity capture LC-MS/MS in quantitative determination of proteins in biological matrices

  2017cites this paper
• The Application of Immunoaffinity‐Based Mass Spectrometry to Characterize Protein Biomarkers and Biotherapeutics

  2017cites this paper
• Calcium and Bone Metabolism Indices.

  2017cites this paper
• Human proteoforms as new targets for clinical mass spectrometry protein tests

  2017cites this paper
• Immunoaffinity techniques coupled to mass spectrometry for the analysis of human peptide hormones: advances and applications

  2017cites this paper
• Perspective and priorities for improvement of parathyroid hormone (PTH) measurement - A view from the IFCC Working Group for PTH.

  2017cites this paper
• The clinical utility of mass spectrometry based protein assays.

  2016cites this paper
• Clinical applications of MS‐based protein quantification

  2016cites this paper
• A Bioanalytical Method for Quantification of Thioredoxins in Bacillus anthracis by Digestion with Immobilized Pepsin and LC–MS/MS and On-line LC/LC–MS/MS

  2016cites this paper
• Round robin test on quantification of amyloid‐β 1–42 in cerebrospinal fluid by mass spectrometry

  2016cites this paper
• Quantitation of Parathyroid Hormone in Serum or Plasma by Liquid Chromatography-Tandem Mass Spectrometry.

  2016cites this paper
• Using Mass Spectrometry to Quantify Rituximab and Perform Individualized Immunoglobulin Phenotyping in ANCA-Associated Vasculitis.

  2016cites this paper
• Identification and quantitation of proteins in human plasma and serum by LC-MS / MS

  2016cites this paper
• Impact of Sample Matrix on Accuracy of Peptide Quantification: Assessment of Calibrator and Internal Standard Selection and Method Validation.

  2016cites this paper
• Clinical peptide and protein quantification by mass spectrometry (MS)

  2016cites this paper
• The use of generic surrogate peptides for the quantitative analysis of human immunoglobulin G1 in pre-clinical species with high-resolution mass spectrometry

  2016cites this paper
• Design and utility of open-access liquid chromatography tandem mass spectrometry in quantitative clinical toxicology and therapeutic drug monitoring

  2016cites this paper
• Featured Article Round robin test on quantification of amyloid-b 1-42 in cerebrospinal fluid by mass spectrometry

  2016cites this paper
• Protein Analysis in the Clinical Immunology Laboratory

  2016cites this paper
• Mass Spectrometry Selectivity, Specifically.

  2016cites this paper
• Parathyroid Hormone (PTH) Assays and Applications to Bone Disease: Overview on Methodology

  2015cites this paper
• ELISA microplate: a viable immunocapture platform over magnetic beads for immunoaffinity-LC-MS/MS quantitation of protein therapeutics?

  2015cites this paper
• Clinical assays for quantitation of insulin-like-growth-factor-1 (IGF1).

  2015cites this paper
• Immunocapture strategies in translational proteomics

  2015cites this paper
• Problems with the PTH assays.

  2015cites this paper
• Quantification of HER 2 by Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded ( FFPE ) Breast Cancer Tissues *

  2015cites this paper
• Quantification of biopharmaceuticals and biomarkers in complex biological matrices: a comparison of liquid chromatography coupled to tandem mass spectrometry and ligand binding assays

  2015cites this paper
• Annales d'Endocrinologie xxx (2015) xxx-xxx

  2015cites this paper
• Paraffin-Embedded Breast Cancer Tissues

  2015cites this paper
• ALDH1A enzymes regulate retinoic acid homeostasis in a tissue specific manner: A model of how novel methods can unravel old unanswered questions

  2015cites this paper
• Chemical labeling strategies for mass spectrometry-based biomolecular identification, characterization and quantification

  2015cites this paper
• Journées Klotz 2015 Problems with the PTH assays Difficultés de dosage de la PTH

  2015cites this paper
• LC-MS-based quantification of intact proteins: perspective for clinical and bioanalytical applications.

  2015cites this paper
• Quantification of HER2 by Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded (FFPE) Breast Cancer Tissues*

  2015cites this paper
• Considerations in parathyroid hormone testing

  2015cites this paper
• Quantitation of human peptides and proteins via MS: review of analytically validated assays.

  2014cites this paper
• PTH: Potential role in management of heart failure.

  2014cites this paper
• Standardization of DiaSorin and Roche automated third generation PTH assays with an International Standard: impact on clinical populations

  2014cites this paper
• LC–MS/MS in the routine clinical laboratory: has its time come?

  2014cites this paper
• LC-MS candidate reference methods for the harmonisation of parathyroid hormone (PTH) measurement: a review of recent developments and future considerations

  2014influential citation
• Assessment of the influence of the patient’s inflammatory state on the accuracy of a haptoglobin selected reaction monitoring assay

  2014cites this paper
• Quantification of serum IgG subclasses by use of subclass-specific tryptic peptides and liquid chromatography--tandem mass spectrometry.

  2014cites this paper
• LC-MS/MS in endocrinology: what is the profit of the last 5 years?

  2014cites this paper
• Design, Implementation and Multisite Evaluation of a System Suitability Protocol for the Quantitative Assessment of Instrument Performance in Liquid Chromatography-Multiple Reaction Monitoring-MS (LC-MRM-MS)*

  2013cites this paper
• The Development and Implementation of LC/MS-Based Bioanalytical Methods for the Quantification of Protein Therapeutics in Drug Discovery

  2013cites this paper
• Bioanalytical LC-MS/MS of protein-based biopharmaceuticals.

  2013cites this paper
• Tandem mass spectrometry in hormone measurement.

  2013cites this paper
• Analysis of biopharmaceutical proteins in biological matrices by LC-MS/MS I. Sample preparation

  2013cites this paper
• La quantification ciblée de protéines et peptides par chromatographie liquide couplée à la spectrométrie de masse en tandem : développements analytiques et applications

  2012cites this paper
• Discrepant intact parathyroid hormone result by immunoassay.

  2012cites this paper
• The coming of age of liquid chromatography coupled to tandem mass spectrometry in the endocrinology laboratory.

  2012cites this paper
• Pitfalls of LC-MS/MS in the Clinical Laboratory

  2012cites this paper
• Expression and characterization of 15N-labeled human C-reactive protein in Escherichia coli and Pichia pastoris for use in isotope-dilution mass spectrometry.

  2012cites this paper
• Quantitative Analysis of Multiple Charged Large Molecules in Human or Rat Plasma Using Liquid Chromatography Tandem Mass Spectrometry

  2012cites this paper
• Stable-Isotope-Labeled Parathyroid Hormone as an Immunocapture and Digestion-Efficiency Internal Standard for MS-Based Immunoassays

  2012cites this paper
• Introducing AAA-MS, a rapid and sensitive method for amino acid analysis using isotope dilution and high-resolution mass spectrometry.

  2012cites this paper
• The role of liquid chromatography-tandem mass spectrometry in the clinical laboratory.

  2012cites this paper
• LC-MS/MS for protein and peptide quantification in clinical chemistry.

  2012cites this paper
• Quantification of circulating D-dimer by peptide immunoaffinity enrichment and tandem mass spectrometry.

  2012cites this paper
• Mass spectrometry-based protein assays for in vitro diagnostic testing

  2012cites this paper
• PSAQ™ standards for accurate MS-based quantification of proteins: from the concept to biomedical applications.

  2012cites this paper
• PTH Assays: Understanding What We Have and Forecasting What We Will Have

  2012cites this paper
• Internal standards in the quantitative determination of protein biopharmaceuticals using liquid chromatography coupled to mass spectrometry.

  2012cites this paper
• Measuring Parathyroid Hormone (PTH) in Patients with Oxidative Stress – Do We Need a Fourth Generation Parathyroid Hormone Assay?

  2012cites this paper
• Differentiation and quantification of endogenous and recombinant-methionyl human leptin in clinical plasma samples by immunocapture/mass spectrometry.

  2012cites this paper